257 related articles for article (PubMed ID: 17915081)
1. When ADHD and substance use disorders intersect: relationship and treatment implications.
Wilens TE; Fusillo S
Curr Psychiatry Rep; 2007 Oct; 9(5):408-14. PubMed ID: 17915081
[TBL] [Abstract][Full Text] [Related]
2. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
[TBL] [Abstract][Full Text] [Related]
3. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use.
Wilens TE
J Clin Psychiatry; 2007; 68 Suppl 11():4-8. PubMed ID: 18307375
[TBL] [Abstract][Full Text] [Related]
4. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
Kollins SH
Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
[TBL] [Abstract][Full Text] [Related]
5. Does ADHD predict substance-use disorders? A 10-year follow-up study of young adults with ADHD.
Wilens TE; Martelon M; Joshi G; Bateman C; Fried R; Petty C; Biederman J
J Am Acad Child Adolesc Psychiatry; 2011 Jun; 50(6):543-53. PubMed ID: 21621138
[TBL] [Abstract][Full Text] [Related]
6. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
Özgen H; Spijkerman R; Noack M; Holtmann M; Schellekens ASA; van de Glind G; Banaschewski T; Barta C; Begeman A; Casas M; Crunelle CL; Daigre Blanco C; Dalsgaard S; Demetrovics Z; den Boer J; Dom G; Eapen V; Faraone SV; Franck J; González RA; Grau-López L; Groenman AP; Hemphälä M; Icick R; Johnson B; Kaess M; Kapitány-Fövény M; Kasinathan JG; Kaye SS; Kiefer F; Konstenius M; Levin FR; Luderer M; Martinotti G; Matthys FIA; Meszaros G; Moggi F; Munasur-Naidoo AP; Post M; Rabinovitz S; Ramos-Quiroga JA; Sala R; Shafi A; Slobodin O; Staal WG; Thomasius R; Truter I; van Kernebeek MW; Velez-Pastrana MC; Vollstädt-Klein S; Vorspan F; Young JT; Yule A; van den Brink W; Hendriks V
Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
[TBL] [Abstract][Full Text] [Related]
7. Impact of substance use disorder on ADHD and its treatment.
Wilens TE; Upadhyaya HP
J Clin Psychiatry; 2007 Aug; 68(8):e20. PubMed ID: 17876905
[TBL] [Abstract][Full Text] [Related]
8. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
Schubiner H
CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
[TBL] [Abstract][Full Text] [Related]
9. The intersection of attention-deficit/hyperactivity disorder and substance abuse.
Wilens TE; Morrison NR
Curr Opin Psychiatry; 2011 Jul; 24(4):280-5. PubMed ID: 21483267
[TBL] [Abstract][Full Text] [Related]
10. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders.
Zulauf CA; Sprich SE; Safren SA; Wilens TE
Curr Psychiatry Rep; 2014 Mar; 16(3):436. PubMed ID: 24526271
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
12. Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.
Wilens TE; Biederman J
J Psychopharmacol; 2006 Jul; 20(4):580-8. PubMed ID: 16174669
[TBL] [Abstract][Full Text] [Related]
13. Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
Molina BS; Hinshaw SP; Eugene Arnold L; Swanson JM; Pelham WE; Hechtman L; Hoza B; Epstein JN; Wigal T; Abikoff HB; Greenhill LL; Jensen PS; Wells KC; Vitiello B; Gibbons RD; Howard A; Houck PR; Hur K; Lu B; Marcus S;
J Am Acad Child Adolesc Psychiatry; 2013 Mar; 52(3):250-63. PubMed ID: 23452682
[TBL] [Abstract][Full Text] [Related]
14. Managing attention-deficit/hyperactivity disorder in the presence of substance use disorder.
Upadhyaya HP
J Clin Psychiatry; 2007; 68 Suppl 11():23-30. PubMed ID: 18307378
[TBL] [Abstract][Full Text] [Related]
15. Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.
Klassen LJ; Bilkey TS; Katzman MA; Chokka P
Curr Drug Abuse Rev; 2012 Sep; 5(3):190-8. PubMed ID: 22571450
[TBL] [Abstract][Full Text] [Related]
16. Methylphenidate in Adults with Attention Deficit Hyperactivity Disorder and Substance Use Disorders.
Simon N; Rolland B; Karila L
Curr Pharm Des; 2015; 21(23):3359-66. PubMed ID: 26088112
[TBL] [Abstract][Full Text] [Related]
17. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.
Wilens TE; Faraone SV; Biederman J; Gunawardene S
Pediatrics; 2003 Jan; 111(1):179-85. PubMed ID: 12509574
[TBL] [Abstract][Full Text] [Related]
18. A naturalistic study of the effects of pharmacotherapy on substance use disorders among ADHD adults.
Faraone SV; Biederman J; Wilens TE; Adamson J
Psychol Med; 2007 Dec; 37(12):1743-52. PubMed ID: 17349106
[TBL] [Abstract][Full Text] [Related]
19. Towards Precision Addiction Treatment: New Findings in Co-morbid Substance Use and Attention-Deficit Hyperactivity Disorders.
Luo SX; Levin FR
Curr Psychiatry Rep; 2017 Mar; 19(3):14. PubMed ID: 28251590
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and characteristics of South African treatment-seeking patients with substance use disorder and co-occurring attention-deficit/hyperactivity disorder.
Coetzee C; Truter I; Meyer A
Expert Rev Clin Pharmacol; 2020 Nov; 13(11):1271-1280. PubMed ID: 33040639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]